Lv31
300 积分 2025-01-20 加入
Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials
5小时前
已完结
Nanoparticle radiosensitizers in cancer radiotherapy: bridging preclinical promise and clinical reality
5小时前
已完结
Nanoscale Radiotherapy with Hafnium Oxide Nanoparticles
7小时前
已完结
Targeting FAK in anticancer combination therapies
21天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
25天前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
25天前
已完结
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
1个月前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
2个月前
已完结
皖公网安备34019202002308
